Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue at hand, China’s lockdown that caused supply chain disruption, the rise in raw material prices, and the Russia-Ukraine war have raised packaging costs.
Violent crypto attacks rise as criminals hunt bigger payouts
Physical attacks targeting cryptocurrency holders surged 33% globally in the first half of 2026, with losses soaring to $124 million. France emerged as the epicentre